Cisco
CSCO
Alibaba
BABA
Disney
DIS
Apple
AAPL
Qualcomm
QCOM
US Stock MarketDetailed Quotes
HRTX Heron Therapeutics
- 2.290
- -0.060-2.55%
Close Mar 26 16:00 ET
- 2.370
- +0.080+3.49%
Post 20:01 ET
348.83MMarket Cap-25.44P/E (TTM)
2.380High2.270Low707.34KVolume2.350Open2.350Pre Close1.64MTurnover0.61%Turnover RatioLossP/E (Static)152.33MShares3.93052wk High-10.36P/B265.71MFloat Cap1.04052wk Low--Dividend TTM116.03MShs Float830.000Historical High--Div YieldTTM4.68%Amplitude0.500Historical Low2.314Avg Price1Lot Size
Heron Therapeutics News
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Collard Craig A
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Duarte Ira
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Forbes William P
Heron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Rodriguez Susan
Heron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Johnson Craig A
Heron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Christian Waage
Heron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Morgan Adam
Heron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Kaseta Michael
Heron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Dissanaike Sharmila
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kaseta Michael
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dissanaike Sharmila
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Johnson Craig A
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rodriguez Susan
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Christian Waage
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Morgan Adam
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Duarte Ira
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Forbes William P
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Collard Craig A
Heron Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adage Capital Management, L.P.(5.84%),Robert Atchinson(5.84%), etc.
Heron Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.6%)
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.